BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17893755)

  • 1. [The importance of microbiological surveillance networks in monitoring resistant bacteria. RedMIVA].
    Muñoz I; Vanaclocha H; González F
    Rev Esp Quimioter; 2007 Jun; 20(2):193-202. PubMed ID: 17893755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring antimicrobial drug resistance in hospital microorganisms. Definition of problems and methods.
    Møller JK
    Dan Med Bull; 1990 Jun; 37(3):263-74. PubMed ID: 2192838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance and future of antimicrobial surveillance studies.
    Masterton R
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S21-31. PubMed ID: 18713046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An electronic network for the surveillance of antimicrobial resistance in bacterial nosocomial isolates in Greece. The Greek Network for the Surveillance of Antimicrobial Resistance.
    Vatopoulos AC; Kalapothaki V; Legakis NJ
    Bull World Health Organ; 1999; 77(7):595-601. PubMed ID: 10444883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacterial resistance to antibiotics. Data from the National Observatory of Bacterial Resistance Epidemiology (ONERBA)].
    Conseil scientifique de l'ONERBA
    Med Mal Infect; 2005 Mar; 35(3):155-69. PubMed ID: 15911185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European recommendations for antimicrobial resistance surveillance.
    Cornaglia G; Hryniewicz W; Jarlier V; Kahlmeter G; Mittermayer H; Stratchounski L; Baquero F;
    Clin Microbiol Infect; 2004 Apr; 10(4):349-83. PubMed ID: 15059129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal use of antibiotic resistance surveillance systems.
    Critchley IA; Karlowsky JA
    Clin Microbiol Infect; 2004 Jun; 10(6):502-11. PubMed ID: 15191377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiologic surveillance in intensive care: how to organize it?].
    Moro ML
    Minerva Anestesiol; 2001 Apr; 67(4):302-6. PubMed ID: 11376529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a program-specific website to disseminate surveillance data obtained from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Study.
    Turner PJ
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):273-9. PubMed ID: 16360551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological interpretation of antibiotic resistance studies - what are we missing?
    Schwaber MJ; De-Medina T; Carmeli Y
    Nat Rev Microbiol; 2004 Dec; 2(12):979-83. PubMed ID: 15550943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status and changing trends of antimicrobial resistance in Lebanon.
    Araj GF; Kanj SS
    J Med Liban; 2000; 48(4):221-6. PubMed ID: 11214193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New trends in regulatory rules and surveillance of antimicrobial resistance in bacteria of animal origin.
    Martel JL; Tardy F; Sanders P; Boisseau J
    Vet Res; 2001; 32(3-4):381-92. PubMed ID: 11432426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance uncovers the smoking gun for resistance emergence.
    Verhoef J; Fluit A
    Biochem Pharmacol; 2006 Mar; 71(7):1036-41. PubMed ID: 16288993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Implementing a community surveillance network to monitor antimicrobial resistance: the Labville network].
    Maugat S; Georges S; Nicolau J; Mevel M; Moreau F; Laurent F; Aubry Damon H; Coignard B
    Med Mal Infect; 2008 May; 38(5):249-55. PubMed ID: 18455340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supranational surveillance of antimicrobial resistance: The legacy of the last decade and proposals for the future.
    Giske CG; Cornaglia G;
    Drug Resist Updat; 2010; 13(4-5):93-8. PubMed ID: 20864384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial.
    Rodloff AC; Leclercq R; Debbia EA; Cantón R; Oppenheim BA; Dowzicky MJ
    Clin Microbiol Infect; 2008 Apr; 14(4):307-14. PubMed ID: 18261126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A framework for global surveillance of antibiotic resistance.
    Grundmann H; Klugman KP; Walsh T; Ramon-Pardo P; Sigauque B; Khan W; Laxminarayan R; Heddini A; Stelling J
    Drug Resist Updat; 2011 Apr; 14(2):79-87. PubMed ID: 21482177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the microbiology laboratory in monitoring and identifying resistance: use of molecular biology.
    Pfaller MA; Cormican MG
    New Horiz; 1996 Aug; 4(3):361-9. PubMed ID: 8856754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving concepts of pharmaceutical company-sponsored surveillance studies.
    Koeth LM; Miller LA
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S279-82. PubMed ID: 16032566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TSN Database Australia, a new tool to monitor antimicrobial resistance in Australia.
    Turnidge J; McCarthy LR; Master RN; Kepner DE; Weslock J
    Commun Dis Intell Q Rep; 2003; 27 Suppl():S67-9. PubMed ID: 12807277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.